Novolog Pharm-Up 1966 Ltd (NVLG) — Cash Flow Quality Index
Novolog Pharm-Up 1966 Ltd (NVLG) has a Cash Flow Quality Index of 3.61x as of September 2025. Operating cash flow of ILA15.42 Million exceeds net income of ILA4.27 Million, indicating high earnings quality where cash backs reported profits. Explore how efficiently does Novolog Pharm-Up 1966 Ltd generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Novolog Pharm-Up 1966 Ltd Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Novolog Pharm-Up 1966 Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check NVLG total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Novolog Pharm-Up 1966 Ltd (2013–2025)
Year-by-year earnings quality comparison for Novolog Pharm-Up 1966 Ltd. For live market cap and the full company financial profile, see NVLG market cap.
| Year | Quality Index | Operating CF (ILA) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -4.01x | ILA-16.50 Million | ILA4.12 Million | ▼ -203.7% |
| 2024 | 3.87x | ILA158.52 Million | ILA40.99 Million | ▲ +49.8% |
| 2022 | 2.58x | ILA132.65 Million | ILA51.40 Million | ▲ +38.7% |
| 2021 | 1.86x | ILA83.39 Million | ILA44.83 Million | ▲ +29.0% |
| 2020 | 1.44x | ILA58.48 Million | ILA40.56 Million | ▼ -85.6% |
| 2019 | 10.01x | ILA101.45 Million | ILA10.14 Million | ▲ +813.0% |
| 2018 | 1.10x | ILA23.96 Million | ILA21.86 Million | ▼ -71.5% |
| 2017 | 3.84x | ILA86.37 Million | ILA22.49 Million | ▲ +451.3% |
| 2016 | 0.70x | ILA20.28 Million | ILA29.12 Million | ▼ -87.5% |
| 2015 | 5.55x | ILA140.29 Million | ILA25.26 Million | ▼ -18.6% |
| 2014 | 6.82x | ILA160.59 Million | ILA23.54 Million | ▲ +280.8% |
| 2013 | -3.77x | ILA-55.79 Million | ILA14.79 Million | — |